82822:HK:HK-CSOP FTSE China A50 (CNY)

ETF | Others |

Last Closing

USD 11.32

Change

+0.02 (+0.18)%

Market Cap

USD 8.25B

Volume

0.33M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

-0.16 (-0.87%)

USD 142.18B
2840:HK SPDR® Gold Shares

+5.50 (+0.33%)

USD 59.08B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

-0.68 (-1.04%)

USD 21.03B
2823:HK iShares FTSE A50 China

-0.03 (-0.24%)

USD 14.81B
3188:HK ChinaAMC CSI 300 Index ETF

-0.40 (-1.01%)

USD 14.60B
83188:HK ChinaAMC CSI 300 Index ETF

+0.22 (+0.60%)

USD 13.48B
2801:HK iShares Core MSCI China ETF

-0.17 (-0.89%)

USD 11.74B
7226:HK CSOP Hang Seng TECH Index Dail..

-0.10 (-2.95%)

USD 10.25B
3067:HK iShares Hang Seng TECH ETF

-0.10 (-1.20%)

USD 9.22B

ETFs Containing 82822:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.80% 69% C- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.80% 68% D+ 67% D+
Trailing 12 Months  
Capital Gain -4.71% 59% D- 64% D
Dividend Return 2.86% 39% F 83% B
Total Return -1.85% 61% D- 64% D
Trailing 5 Years  
Capital Gain -7.97% 41% F 72% C
Dividend Return 10.08% 74% C 36% F
Total Return 2.11% 54% F 71% C-
Average Annual (5 Year Horizon)  
Capital Gain -2.69% 63% D 56% F
Dividend Return -0.83% 67% D+ 57% F
Total Return 1.85% 60% D- 38% F
Risk Return Profile  
Volatility (Standard Deviation) 16.75% 53% F 80% B-
Risk Adjusted Return -4.97% 68% D+ 56% F
Market Capitalization 8.25B 73% C 82% B

Annual Financials (CNY)

Quarterly Financials (CNY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike